A carregar...
Clinical Development of PD-1 Blockade in Hematologic Malignancies
Clinical development of Immune checkpoint inhibitors targeting the programmed cell death 1 (PD-1) pathway has led to clinical benefits for patients with multiple solid tumor and hematologic malignancies and has revolutionized modern oncology. High response rates to PD-1 blockade in patients with cla...
Na minha lista:
| Publicado no: | Cancer J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5785103/ https://ncbi.nlm.nih.gov/pubmed/29360725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000297 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|